Monday 05 October 11:00-12:30
Who are the highest risk patients and how do we manage them?
-
Anne Tybjærg-Hansen, Denmark
Anne Tybjærg-Hansen
Copenhagen, Denmark
Anne Tybjærg-Hansen is Chief Physician at the Department of Clinical Biochemistry, Section for Molecular Genetics, at Rigshospitalet, Copenhagen University Hospital, Copenhagen, as well as Professor of Clinical Biochemistry with Focus on Translational Molecular Cardiology at the University of Copenhagen, Copenhagen, Denmark. After completing her medical degree at the University of Copenhagen, she undertook additional studies at the University of Copenhagen and the Lipid Clinic at Righospitalet, Hagedorn Research Laboratory, Gentofte, Denmark, and the British Heart Foundation’s Molecular Biology Research Group, London, UK. Professor Tybjaerg-Hansen has made major contributions to the understanding of the genetics of lipoproteins and their association with atherosclerotic cardiovascular disease. She is a member of the steering committees of the Copenhagen City Heart Study and the Copenhagen General Population Study, and a member of the European Atherosclerosis Consensus Panel, contributing to statements on familial hypercholesterolaemia, hypertriglyceridaemia, triglyceride-rich lipoproteins and high-density lipoprotein, and lipoprotein(a). Professor Tybjaerg-Hansen was the recipient of the Anitschkow Award presented by the European Atherosclerosis Society in 2018.
- Dan Gaita, Romania
Chronic kidney disease patients
Colin Baigent, Oxford, UK
Acute coronary syndrome patients
Jose Luis Zamorano, Spain
Tuesday 06 October 11:00-11:40
Controversies in nutrition
- Evangelos Liberopoulos, Greece
- Pedro Valdivielso Felices, Spain
To what extent can functional ingredients and supplements that lower LDL-C play a role in CVD risk management?
Sabine Baumgartner, The Netherlands
Which diet works best for cardiovascular prevention?
Sun Qi, USA
Tuesday 06 October 15:30-17:00
Lipid lowering therapies from childhood to old age
- Frederick Raal, South Africa
- Steve Humphries, UK
Treating primary dyslipidemia in children: what we’ve learned from treating patients with Familial Hypercholesterolemia
Marina Cuchel, USA
Lipid lowering therapies in a global perspective
Cherian Varghese, Geneva, Switzerland
Wednesday 07 October 11:00-12:30
Strategies towards personalized risk stratification
- Ionna Gouni-Berthold, Germany
- Gerald Tomkin, Ireland
Refinement of risk prediction by imaging
Paolo Raggi, Alberta, Canada
Refinement of risk prediction by circulating biomarkers
Stefan Blankenberg, Germany
Monday 05 October 11:00-12:30
Non coding RNA and distant regulators
- Manuel Mayr, UK
- Christina Christoffersen, Denmark
The multifactorial nature of microRNAs in vascular remodelling
Yael Nossent, Vienna, Austria
High-resolution regulatory maps connect vascular risk variants to disease-related pathways
Pelin Sahlén, Sweden
Monday 05 October 15:45-17:15
Immune cells in the arterial wall
- Marit Westerterp, The Netherlands
- Christoph Binder, Austria
Inflammasome, neutrophil extracellular traps and cholesterol
Marit Westerterp, Groningen, The Netherlands
Transcriptomic landscape and heterogeneity of macrophages in atherosclerosis.
Alma Zernecke, Würzburg, Germany
Tuesday 06 October 11:00-12:30
Lipoproteins in the arterial wall
- Winfried März, Germany
- Henry Ginsberg, USA
LDL aggregation
Katariina Öörni, Helsinki, Finland
Transendothelial transport
Philip Shaul, USA
Wednesday 07 October 11:00-12:30
Plaque rupture and erosion
- Margus Viigimaa, Estonia
- Thorsten Hornemann, Switzerland
Microvesicles and endothelial activation
Lina Badimon, Barcelona, Spain
Vulnerable plaque: Current concepts in pathophysiology and imaging
Oliver Soehnlein, Munich, Germany
Monday 05 October 11:00-12:30
Lipoprotein receptors and transporters
- Danilo Norata, Italy
- Noam Zelcer, The Netherlands
Role of the retromer COMMD/WASH complex
Bart van de Sluis, Groningen, The Netherlands
Lipoprotein transport in the brain
Francesca Zimetti, Parma, Italy
Tuesday 06 October 11:00-12:30
Regulation and transport of sterols
- Xavier Collet, France
- Paolo Parini, Sweden
The role of FXR in reverse cholesterol transport
Folkert Kuipers, Groningen, The Netherlands
G-protein coupled bile acid receptors
Elena Osto, Czech Republic
Tuesday 06 October 15:30-17:00
Adipose tissue
- Patrick Rensen, The Netherlands
- Olivier Descamps, Belgium
Browning of white adipose tissue
Alexander Bartelt, Germany
Whitening of brown adipose tissue - role of the mevalonate pathwa
Christian Wolfrum, Zürich, Switzerland
Wednesday 07 October 11:00-12:30
Cellular lipid trafficking
- Bart Staels, France
- Vesa Olkkonen, Finland
Intracellular cholesterol trafficking
Elina Ikonen, Helsinki, Finland
Impact of lipid droplets - implications for human disease
Tobias Walther, USA
Bob Farese, USA
